Biotech stocks are seeing significant pre-market activity this Wednesday. Pre-market movers give traders an early read on momentum, sentiment, and potential volatility for the trading day.
In the Green - Premarket Gainers
On Wednesday, the following stocks were trading significantly higher in the premarket session.
1. Nuwellis, Inc. (NUWE) - up 28% at $1.222. Summit Therapeutics Inc. (SMMT) - up 16% at $15.503. VolitionRx Ltd. (VNRX) - up 12% at $0.434. Celularity Inc. (CELU) - up 8% at $0.875. TherapeuticsMD, Inc. (TXMD) - up 8% at $2.456. Actuate Therapeutics, Inc. (ACTU) - up 8% at $1.707. Arcadia Biosciences, Inc. (RKDA) - up 7% at $0.528. Biodesix, Inc. (BDSX) - up 7% at $29.789. Scribe Therapeutics Inc. (SCTX) - up 6% at $33.1910. TransCode Therapeutics, Inc. (RNAZ) - up 6% at $2.67
For comments and feedback contact: editorial@rttnews.com
Economic News
What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.